Supplement Industry Plants Longtime Use Flag As US Looks At Expanding…

The supplement industry is lobbying to include peptides in the FDA's compounding bulk drug list expansion, seeking to legitimise longtime use of peptide ingredients under a regulatory umbrella currently reserved for pharmaceuticals. The move could reshape how peptide-based supplements are classified and regulated in the US market. If you're selling peptide supplements, the industry just opened a door to FDA legitimacy that your competitors don't know about yet. An advisory committee vote on peptide inclusion in the compounding bulk drug list could move your product from 'unregulated supplement' to 'regulated active ingredient'—that's regulatory cover and a moat.